Home > Collections > Topics in Regulatory Affairs for Pharmaceuticals
Topics in Regulatory Affairs for Pharmaceuticals
View PDF

Topics in Regulatory Affairs for Pharmaceuticals

Publisher: FX Conferences
  • Description

Stay current on the ever-changing regulatory environment with 10 audio recordings of industry experts offering practical guidance for executives, directors, managers, and associates concerned with regulations in the pharmaceutical market.

Ovid and FX Conferences offer thousands of professional development hours for your teams, conveniently packaged and delivered as a collection of audio recordings to save you time and money.

Topics in this collection have a global appeal and are relevant for multiple departments within your organization—R & D, Market Research, Compliance, and more. Each of the 10 recordings consists of a 45-minute, telephone-based presentation delivered by expert international speakers, followed by a 15-minute question-and-answer session (collection available with and without transcripts).

RECORDINGS:

1. Requests for Off-label Information – The FDA Guidance and Its Implications
Speakers: Wendy Blackburn, Executive Vice President, Intouch Solutions, and Dr. Darshan Kulkarni, Principal Attorney, The Kulkarni Law Firm

2. Preparing for Upcoming Changes in EU Pharmacovigilance Requirements
Speaker: Dr. Jan Petracek, CEO & Chief Consultant, PharmInvent

3. Industry Update – Europe's New Pharmacovigilance Regulations
Speaker: Stefan Blesse, Principal Consultant, Granzer Regulatory Consulting & Services

4. Effectively Managing an FDA Inspection – Opening Meeting to Rapid 483 Response
Speaker: John Avellanet, Managing Director & Principal, Cerulean Associates LLC

5. FDA Update – Responding to Unsolicited Requests for Off-Label Information
Speakers: Marian J. Lee, Partner, and Beverly H. Lorell, Senior Adviser, King & Spalding LLP

6. Centralized vs Onsite Monitoring – Applying FDA's Risk-based Approach
Speaker: Sandra Maddock, President & CEO, IMARC Research, Inc

7. Off-label Promotion – What FDA Looks For & What You Need to Know
Speaker: Alan Minsk, Partner, Arnall Golden Gregory LLP

8. Expedited and Periodic Safety Reporting for Drug Trials
Speakers: Helen Colquhoun, Vice President, Cromsource

9. Following the 510(k) and 505(b)(2) Pathways to Regulatory Approval
Speaker: Dr. Joy Frestedt. President & CEO, Frestedt Incorporate

10. Successfully Responding to FDA 483s and Warning Letters
Speaker: Michael A. Swit, Special Counsel, FDA Practice, Duane Morris LLP

Free Instant Access
This Month

JOTM
Visible Body Human Anatomy Atlas This award-winning human anatomy general reference is a 3D visualization and learning tool used to interact with and explore the systems of the human body.
JOTM
PsycINFO® A comprehensive international bibliographic database, PsycINFO® provides access to more than 4 million citations in 29 languages.
JOTM
Journal of Orthopaedics for Physician Assistants The JBJS Journal of Orthopaedics for Physician Assistants is an academic resource that delivers ongoing orthopaedic education for physician assistants and nurse practitioners.
JOTM
Harvard Review of Psychiatry Founded by the Harvard Medical School’s Department of Psychiatry, this is the authoritative source for scholarly reviews and perspectives on important topics in psychiatry.

Noteworthy

Doody's Featured Books
Orthopaedic Basic Science: Foundations of Clinical Practice, 4th Edition
Concise and clinically relevant resource for the diagnosis and treatment of musculoskeletal diseases and conditions.

AAOS Comprehensive Orthopaedic Review, 2nd Edition
Offers sweeping coverage of core orthopaedic knowledge that spans the spectrum of the orthopaedic specialties.